home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Fueling Fire In The Gut

 
  June, 14 2005 12:46
your information resource in human molecular genetics
 
     
Our intestines have specialized cells that promote immune responses to various stimuli in their environment, according to a new report in the July 2005 issue of Nature Immunology. This finding could have implications for the development of effective oral vaccines, for which a strong immune response is desired, as well as for the treatment of inflammatory bowel diseases, such as Crohn's disease, for which dampening of inflammation is important. Currently around 600,000 Americans have some form of inflammatory bowel disease every year.

Conventional wisdom suggests that the gut favors a 'mild' local environment because it is necessary for us to live in harmony with a community of beneficial bacteria. However, the gut does respond to harmful bacteria and sometimes to harmless bacteria to cause inflammation. Manjunath and colleagues found that certain cells that produce a molecule called CD70 and reside in a region known as the lamina propria, which is just under the surface of the intestine. These CD70-producing cells are critical for expanding the number of immune T cells during an infection. The cells also help to further equip these T cells with offensive potentials.

Although the precise identity of the CD70-producing cells is still elusive, it is clear that the CD70 molecule is crucial in inducing a heightened immune response. Thus, targeting CD70 and its interacting partner on T cells provides the basis for further investigation into the control of gut immunity.

Author contact:

N. Manjunath (Harvard Medical School, Boston, MA, USA)
Email: swamy@cbr.med.harvard.edu

Additional contact for comments on paper:

Brian L. Kelsall (National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA)
E-mail: bkelsall@niaid.nih.gov

Also published online(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.